Table of Content

1 Study Coverage
1.1 Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Product Introduction
1.2 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Outlook 2018 VS 2024 VS 2034
1.2.1 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in US$ Million for the Year 2018-2034
1.2.2 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume for the Year 2018-2034
1.3 India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Outlook 2018 VS 2024 VS 2034
1.3.1 India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in US$ Million for the Year 2018-2034
1.3.2 India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume for the Year 2018-2034
1.4 Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Size, India VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Size, India VS Global, 2018 VS 2024 VS 2034
1.5 Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Dynamics
1.5.1 Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Industry Trends
1.5.2 Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Drivers
1.5.3 Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Challenges
1.5.4 Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors by Type
2.1 Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Segment by Type
2.1.1 Injection
2.1.2 Pill
2.2 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Size by Type
2.2.1 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Size by Type
2.3.1 India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors by Application
3.1 Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Segment by Application
3.1.1 Aldult
3.1.2 Child
3.2 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Size by Application
3.2.1 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Size by Application
3.3.1 India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Competitor Landscape by Company
4.1 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Size by Company
4.1.1 Global Key Manufacturers of Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors, Ranked by Revenue (2024)
4.1.2 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Revenue by Manufacturer (2018-2023)
4.1.3 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales by Manufacturer (2018-2023)
4.1.4 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Price by Manufacturer (2018-2023)
4.2 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Concentration Ratio (CR)
4.2.1 Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors in 2024
4.2.3 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors, Product Offered and Application
4.5 Global Key Manufacturers of Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Size by Company
4.7.1 Key Players of Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors in India, Ranked by Revenue (2024)
4.7.2 India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Revenue by Players (2018-2023)
4.7.3 India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales by Players (2018-2023)
5 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Size by Region
5.1 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Size in Volume by Region (2018-2034)
5.2.1 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume by Region: 2018-2023
5.2.2 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume Forecast by Region (2024-2034)
5.3 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Size in Value by Region (2018-2034)
5.3.1 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value by Region: 2018-2023
5.3.2 Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Size YoY Growth 2018-2034
6.2 Americas Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Size YoY Growth 2018-2034
7.2 EMEA Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Size YoY Growth 2018-2034
8.2 China Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Size YoY Growth 2018-2034
9.2 APAC Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Gilead Sciences, Inc
10.1.1 Gilead Sciences, Inc Company Information
10.1.2 Gilead Sciences, Inc Description and Business Overview
10.1.3 Gilead Sciences, Inc Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Gilead Sciences, Inc Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Products Offered
10.1.5 Gilead Sciences, Inc Recent Development
10.2 Emcure Pharmaceuticals Limited
10.2.1 Emcure Pharmaceuticals Limited Company Information
10.2.2 Emcure Pharmaceuticals Limited Description and Business Overview
10.2.3 Emcure Pharmaceuticals Limited Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Emcure Pharmaceuticals Limited Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Products Offered
10.2.5 Emcure Pharmaceuticals Limited Recent Development
10.3 Cipla Inc
10.3.1 Cipla Inc Company Information
10.3.2 Cipla Inc Description and Business Overview
10.3.3 Cipla Inc Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Cipla Inc Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Products Offered
10.3.5 Cipla Inc Recent Development
10.4 Hetero
10.4.1 Hetero Company Information
10.4.2 Hetero Description and Business Overview
10.4.3 Hetero Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Hetero Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Products Offered
10.4.5 Hetero Recent Development
10.5 Bausch Health Companies Inc
10.5.1 Bausch Health Companies Inc Company Information
10.5.2 Bausch Health Companies Inc Description and Business Overview
10.5.3 Bausch Health Companies Inc Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Bausch Health Companies Inc Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Products Offered
10.5.5 Bausch Health Companies Inc Recent Development
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Company Information
10.6.2 Johnson & Johnson Description and Business Overview
10.6.3 Johnson & Johnson Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Johnson & Johnson Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Products Offered
10.6.5 Johnson & Johnson Recent Development
10.7 Mylan NV
10.7.1 Mylan NV Company Information
10.7.2 Mylan NV Description and Business Overview
10.7.3 Mylan NV Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Mylan NV Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Products Offered
10.7.5 Mylan NV Recent Development
10.8 Teva Pharmaceutical Industries Ltd
10.8.1 Teva Pharmaceutical Industries Ltd Company Information
10.8.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
10.8.3 Teva Pharmaceutical Industries Ltd Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Teva Pharmaceutical Industries Ltd Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Products Offered
10.8.5 Teva Pharmaceutical Industries Ltd Recent Development
10.9 Sanofi
10.9.1 Sanofi Company Information
10.9.2 Sanofi Description and Business Overview
10.9.3 Sanofi Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Sanofi Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Products Offered
10.9.5 Sanofi Recent Development
10.10 Novartis AG
10.10.1 Novartis AG Company Information
10.10.2 Novartis AG Description and Business Overview
10.10.3 Novartis AG Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Novartis AG Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Products Offered
10.10.5 Novartis AG Recent Development
10.11 Sun Pharmaceutical Industries Ltd
10.11.1 Sun Pharmaceutical Industries Ltd Company Information
10.11.2 Sun Pharmaceutical Industries Ltd Description and Business Overview
10.11.3 Sun Pharmaceutical Industries Ltd Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Sun Pharmaceutical Industries Ltd Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Products Offered
10.11.5 Sun Pharmaceutical Industries Ltd Recent Development
10.12 Aurobindo Pharma
10.12.1 Aurobindo Pharma Company Information
10.12.2 Aurobindo Pharma Description and Business Overview
10.12.3 Aurobindo Pharma Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Aurobindo Pharma Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Products Offered
10.12.5 Aurobindo Pharma Recent Development
10.13 Biocon
10.13.1 Biocon Company Information
10.13.2 Biocon Description and Business Overview
10.13.3 Biocon Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Biocon Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Products Offered
10.13.5 Biocon Recent Development
10.14 Bristol-Myers Squibb Company
10.14.1 Bristol-Myers Squibb Company Company Information
10.14.2 Bristol-Myers Squibb Company Description and Business Overview
10.14.3 Bristol-Myers Squibb Company Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Bristol-Myers Squibb Company Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Products Offered
10.14.5 Bristol-Myers Squibb Company Recent Development
10.15 GlaxoSmithKline plc
10.15.1 GlaxoSmithKline plc Company Information
10.15.2 GlaxoSmithKline plc Description and Business Overview
10.15.3 GlaxoSmithKline plc Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.15.4 GlaxoSmithKline plc Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Products Offered
10.15.5 GlaxoSmithKline plc Recent Development
10.16 Laurus Labs
10.16.1 Laurus Labs Company Information
10.16.2 Laurus Labs Description and Business Overview
10.16.3 Laurus Labs Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Laurus Labs Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Products Offered
10.16.5 Laurus Labs Recent Development
10.17 Flamingo Pharma Limited
10.17.1 Flamingo Pharma Limited Company Information
10.17.2 Flamingo Pharma Limited Description and Business Overview
10.17.3 Flamingo Pharma Limited Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Flamingo Pharma Limited Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Products Offered
10.17.5 Flamingo Pharma Limited Recent Development
10.18 Shanghai Desano Pharmaceuticals Co., Ltd
10.18.1 Shanghai Desano Pharmaceuticals Co., Ltd Company Information
10.18.2 Shanghai Desano Pharmaceuticals Co., Ltd Description and Business Overview
10.18.3 Shanghai Desano Pharmaceuticals Co., Ltd Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Shanghai Desano Pharmaceuticals Co., Ltd Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Products Offered
10.18.5 Shanghai Desano Pharmaceuticals Co., Ltd Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Industry Chain Analysis
11.2 Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Production Mode & Process
11.4 Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales and Marketing
11.4.1 Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales Channels
11.4.2 Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Distributors
11.5 Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors CAGR in Value, India VS Global, 2018 VS 2024 VS 2034
Table 2. Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Trends
Table 3. Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Drivers
Table 4. Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Challenges
Table 5. Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Restraints
Table 6. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Revenue Share by Manufacturer, 2018-2023
Table 13. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales Share by Manufacturer, 2018-2023
Table 15. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors as of 2024)
Table 18. Global Key Manufacturers of Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors, Product Offered and Application
Table 20. Global Key Manufacturers of Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors in India, Ranked by Revenue (2024) & (US$ million)
Table 23. India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Revenue by Players, (US$ Million), (2018-2023)
Table 24. India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Revenue Share by Players, (2018-2023)
Table 25. India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales by Players, (K Units), (2018-2023)
Table 26. India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales Share by Players, (2018-2023)
Table 27. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume by Country (2024-2034) & (K Units)
Table 47. Gilead Sciences, Inc Company Information
Table 48. Gilead Sciences, Inc Description and Business Overview
Table 49. Gilead Sciences, Inc Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Gilead Sciences, Inc Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Product
Table 51. Gilead Sciences, Inc Recent Development
Table 52. Emcure Pharmaceuticals Limited Company Information
Table 53. Emcure Pharmaceuticals Limited Description and Business Overview
Table 54. Emcure Pharmaceuticals Limited Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. Emcure Pharmaceuticals Limited Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Product
Table 56. Emcure Pharmaceuticals Limited Recent Development
Table 57. Cipla Inc Company Information
Table 58. Cipla Inc Description and Business Overview
Table 59. Cipla Inc Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. Cipla Inc Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Product
Table 61. Cipla Inc Recent Development
Table 62. Hetero Company Information
Table 63. Hetero Description and Business Overview
Table 64. Hetero Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Hetero Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Product
Table 66. Hetero Recent Development
Table 67. Bausch Health Companies Inc Company Information
Table 68. Bausch Health Companies Inc Description and Business Overview
Table 69. Bausch Health Companies Inc Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. Bausch Health Companies Inc Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Product
Table 71. Bausch Health Companies Inc Recent Development
Table 72. Johnson & Johnson Company Information
Table 73. Johnson & Johnson Description and Business Overview
Table 74. Johnson & Johnson Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Johnson & Johnson Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Product
Table 76. Johnson & Johnson Recent Development
Table 77. Mylan NV Company Information
Table 78. Mylan NV Description and Business Overview
Table 79. Mylan NV Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Mylan NV Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Product
Table 81. Mylan NV Recent Development
Table 82. Teva Pharmaceutical Industries Ltd Company Information
Table 83. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 84. Teva Pharmaceutical Industries Ltd Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Teva Pharmaceutical Industries Ltd Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Product
Table 86. Teva Pharmaceutical Industries Ltd Recent Development
Table 87. Sanofi Company Information
Table 88. Sanofi Description and Business Overview
Table 89. Sanofi Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Sanofi Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Product
Table 91. Sanofi Recent Development
Table 92. Novartis AG Company Information
Table 93. Novartis AG Description and Business Overview
Table 94. Novartis AG Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Novartis AG Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Product
Table 96. Novartis AG Recent Development
Table 97. Sun Pharmaceutical Industries Ltd Company Information
Table 98. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 99. Sun Pharmaceutical Industries Ltd Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Sun Pharmaceutical Industries Ltd Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Product
Table 101. Sun Pharmaceutical Industries Ltd Recent Development
Table 102. Aurobindo Pharma Company Information
Table 103. Aurobindo Pharma Description and Business Overview
Table 104. Aurobindo Pharma Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Aurobindo Pharma Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Product
Table 106. Aurobindo Pharma Recent Development
Table 107. Biocon Company Information
Table 108. Biocon Description and Business Overview
Table 109. Biocon Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Biocon Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Product
Table 111. Biocon Recent Development
Table 112. Bristol-Myers Squibb Company Company Information
Table 113. Bristol-Myers Squibb Company Description and Business Overview
Table 114. Bristol-Myers Squibb Company Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Bristol-Myers Squibb Company Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Product
Table 116. Bristol-Myers Squibb Company Recent Development
Table 117. GlaxoSmithKline plc Company Information
Table 118. GlaxoSmithKline plc Description and Business Overview
Table 119. GlaxoSmithKline plc Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. GlaxoSmithKline plc Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Product
Table 121. GlaxoSmithKline plc Recent Development
Table 122. Laurus Labs Company Information
Table 123. Laurus Labs Description and Business Overview
Table 124. Laurus Labs Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Laurus Labs Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Product
Table 126. Laurus Labs Recent Development
Table 127. Flamingo Pharma Limited Company Information
Table 128. Flamingo Pharma Limited Description and Business Overview
Table 129. Flamingo Pharma Limited Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. Flamingo Pharma Limited Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Product
Table 131. Flamingo Pharma Limited Recent Development
Table 132. Shanghai Desano Pharmaceuticals Co., Ltd Company Information
Table 133. Shanghai Desano Pharmaceuticals Co., Ltd Description and Business Overview
Table 134. Shanghai Desano Pharmaceuticals Co., Ltd Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 135. Shanghai Desano Pharmaceuticals Co., Ltd Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Product
Table 136. Shanghai Desano Pharmaceuticals Co., Ltd Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Customers List
Table 140. Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Product Picture
Figure 2. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Size 2018-2034 (US$ Million)
Figure 4. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales 2018-2034 (K Units)
Figure 5. India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Size 2018-2034 (US$ Million)
Figure 7. India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales 2018-2034 (K Units)
Figure 8. India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Report Years Considered
Figure 11. Product Picture of Injection
Figure 12. Product Picture of Pill
Figure 13. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Share by Type in 2024 & 2034
Figure 14. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value by Type (2018-2034) & (US$ Million)
Figure 15. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales Market Share in Value by Type (2018-2034)
Figure 16. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales by Type (2018-2034) & (K Units)
Figure 17. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales Market Share in Volume by Type (2018-2034)
Figure 18. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Price by Type (2018-2034) & (US$/Unit)
Figure 19. India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Share by Type in 2024 & 2034
Figure 20. India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value by Type (2018-2034) & (US$ Million)
Figure 21. India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales Market Share in Value by Type (2018-2034)
Figure 22. India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales by Type (2018-2034) & (K Units)
Figure 23. India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales Market Share in Volume by Type (2018-2034)
Figure 24. India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Price by Type (2018-2034) & (US$/Unit)
Figure 25. Product Picture of Aldult
Figure 26. Product Picture of Child
Figure 27. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Share by Application in 2024 & 2034
Figure 28. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value by Application (2018-2034) & (US$ Million)
Figure 29. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales Market Share in Value by Application (2018-2034)
Figure 30. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales by Application (2018-2034) & (K Units)
Figure 31. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales Market Share in Volume by Application (2018-2034)
Figure 32. Global Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Price by Application (2018-2034) & (US$/Unit)
Figure 33. India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Market Share by Application in 2024 & 2034
Figure 34. India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value by Application (2018-2034) & (US$ Million)
Figure 35. India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales Market Share in Value by Application (2018-2034)
Figure 36. India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales by Application (2018-2034) & (K Units)
Figure 37. India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales Market Share in Volume by Application (2018-2034)
Figure 38. India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Price by Application (2018-2034) & (US$/Unit)
Figure 39. Americas Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 40. Americas Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 41. Americas Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales by Type (2018-2034) & (K Units)
Figure 42. Americas Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales Market Share in Volume by Type (2018-2034)
Figure 43. Americas Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales by Application (2018-2034) & (K Units)
Figure 44. Americas Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales Market Share in Volume by Application (2018-2034)
Figure 45. United States Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 46. Canada Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 47. Mexico Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 48. Brazil Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 49. EMEA Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 50. EMEA Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 51. EMEA Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales by Type (2018-2034) & (K Units)
Figure 52. EMEA Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales Market Share in Volume by Type (2018-2034)
Figure 53. EMEA Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales by Application (2018-2034) & (K Units)
Figure 54. EMEA Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales Market Share in Volume by Application (2018-2034)
Figure 55. Europe Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 56. Middle East Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 57. Africa Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 58. China Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 59. China Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 60. China Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales by Type (2018-2034) & (K Units)
Figure 61. China Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales Market Share in Volume by Type (2018-2034)
Figure 62. China Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales by Application (2018-2034) & (K Units)
Figure 63. China Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales Market Share in Volume by Application (2018-2034)
Figure 64. APAC Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 65. APAC Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 66. APAC Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales by Type (2018-2034) & (K Units)
Figure 67. APAC Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales Market Share in Volume by Type (2018-2034)
Figure 68. APAC Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales by Application (2018-2034) & (K Units)
Figure 69. APAC Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales Market Share in Volume by Application (2018-2034)
Figure 70. Japan Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 71. South Korea Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 72. China Taiwan Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 73. Southeast Asia Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 74. India Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Value Chain
Figure 76. Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed